Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...
Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/de...
Japanese startup Spiber has recently announced initiation of a joint research and development project using Spiber&rsquo...
Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...
Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acq...
Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and ...
Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlib...
Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both com...
FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...
Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...
US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for ...
Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstra...
Akili Interactive, digital medicine company creating prescription treatments for people living with cognitive dysfunctio...
Santen Pharmaceutical Co., Ltd. (Santen) announced on March 8 that as part of its initiatives to increase publ...
Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an...
In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...
Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules de...
Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Gr...
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and fa...
Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals, a Nichi-Iko Group Company, a leader of specialty pharmaceutical pro...
Tokyo based AGC Inc. has announced on March 4 the completion of its acquisition of Spain's synthetic...
Thermo Fisher Scientific recently announced that the Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory a...
CAC Corporation has signed a partnership agreement with rfxcel Corporation in the pharmaceutical traceability field...
AbbVie and Eisai have announced that they have received approval for an additional indication of HUMIRA®, a fully hu...
The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of ...
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030...
Generex Biotechnology has announced that the company’s subsidiary Regentys Corporation, a clinical stage regenerat...
KCI, an Acelity Company, recently announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan...
Fujitsu has announced the development of Fujitsu Healthcare Solution Healthcare Personal service Platform, a platform-as...
Eisai Co., Ltd. has announced that it has submitted an application to the European Medicines Agency (EMA) for its in-hou...
Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...
Seattle Genetics, Inc. has announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval fro...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...
Hitachi, Ltd., Jichi Medical University (JMU), International University of Health and Welfare (IUHW) and Chuo University...
Codexis, Inc. has recently announced a multi-year, exclusive supply agreement with KYORIN Pharmaceutical Co., Ltd. for t...
Kyowa Hakko Kirin Co., Ltd. announced the initiation of a phase 2 clinical study in Japan for tenapanor, a small mol...
Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare and ultr...
Chugai Pharmaceutical has announced that Roche has joined the World Federation of Hemophilia (WFH) Humanitarian Aid...
Taiho Pharmaceutical and Cullinan Oncology, LLC announced an agreement to develop TAS6417, a novel EGFR (epidermal growt...
Promega Corporation has announced FALCO biosystems of Kyoto, Japan, a core business company of FALCO HOLDINGS, working i...
Kaneka Corporation, Tokyo has entered into a strategic and investment agreement with an undisclosed US-based medical dev...
Sosei Group Corporation has announced that it has entered into a structured financing agreement with Medicxi, a venture ...
Chugai Pharmaceutical has announced that Roche has received notification that the EU Committee for Medicinal Produ...
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...
Bayer and Kyoto University have agreed on a strategic research alliance to jointly identify new drug targets for the tre...
Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...
apceth Biopharma GmbH, a contract manufacturing organization in the field of cell and gene therapy has announced that Hi...
Chinese healthcare solution leader Huadong Ningbo Medicine Co., Ltd. showcased its biotechnological skincare b...
Santen SA and NextPharma have announced that Santen’s Tampere manufacturing facility and related operations will b...
Fujitsu has enhanced its clinical trial-supporting Fujitsu Life Science Solution tsClinical DDworks21 series with the la...
The WHO has appointed Dr Takeshi Kasai as Regional Director for WHO’s Western Pacific Region, and re-app...
Toray Industries, Inc. and Meiji Seika Pharma Co., Ltd. have announced that the companies have signed an exclusive licen...
FlowForma®, the leading provider of Process Automation tools for Microsoft Office 365®, has announced that Nipro...
QIAGEN N.V. recently announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the thera...
The Polyplastics Group has announced the development of the DURACON(R) polyoxymethylene (POM) PM series for drug contact...
Eisai Co., Ltd. has been listed in the 2019 Global 100 Most Sustainable Corporations in the World (Global 100), a global...
The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...
Thyas has signed a licensing agreement with iPS Academia Japan, Inc. (iPS-AJ), a technology licensing organization of in...
Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Tokyo Institute of Technology have announced that ...
Amgen and UCB announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...
Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...
NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery...
Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (&...
FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in ...
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...
Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therap...
Takeda Pharmaceutical has announced new research collaborations in immuno-oncology (I-O), an area of key strategic...
Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various ce...
MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pl...
Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myer...
A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents ...
Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...
Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazola...
Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in&nb...
Biopharmaceutical company Alvotech has announced that Japan-based Fuji Pharma has acquired a 4.2% stake in the business ...
Following the announcement of positive results from Janssen’s Phase III open-label long-term extension study, whic...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity a...
Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003...
The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support f...
The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Li...
China-based HitGen announced that the company has entered into a drug discovery research collaboration with Mitsubishi T...
Mundipharma and Hisamitsu Pharmaceutical have agreed that Hisamitsu Pharmaceutical will end distribution of dermally abs...
The Union Cabinet chaired by Prime Minister Narendra Modi today has given its ex-post facto approval on the Memoran...
Daiichi Sankyo Company, Limited announced that updated efficacy and safety results from the ongoing phase 1/2 study...
AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered in...
VSee, the telehealth company behind NASA International Space Station, Walgreens, MDLIVE, DaVita, Trinity, Ascension and ...
Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. Thes...
Sun Pharmaceutical, recently announced that it has entered into a definitive agreement to acquire Pola Pharma Inc. (&ldq...
Singapore - The fact that Japanese people have the longest lifespan in the world—and that they live healthier well...
Ono Pharmaceutical announced today that ONO has submitted in Japan an application for manufacturing and marketing ...
Daiichi Sankyo Company, Limited has launched the antitumor agent trastuzumab Biosimilar for intravenous drip infusions 6...
Sysmex Corporation, a Japanese in vitro diagnostics company, and MolecularMD Corporation, a US based molecular diagnosti...
Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...
Eisai Co., Ltd. has announced that the latest information on its in-house discovered and developed anticancer agent erib...
Mitsui & Co. ("Mitsui") on November 21, 2018, acquired a stake in GOQii Inc. ("GOQii"), a business providing a preve...
